• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540694
INE236W01016
47.6465918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
39.79
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

him teknoforge ltd
SIL Investments reports consolidated net loss of Rs 9.10 crore in the March 2026 quarter
May 14,2026
Net Loss of SIL Investments reported to Rs 9.10 crore in the quarter ended March 2026 as against net loss of Rs 2.69 crore during the previous quarter ended March 2025. Sales reported to Rs -5.64 crore in the quarter ended March 2026 as against Rs 0.58 crore during the previous quarter ended March 2025.

For the full year,net profit rose 22.28% to Rs 37.82 crore in the year ended March 2026 as against Rs 30.93 crore during the previous year ended March 2025. Sales rose 14.52% to Rs 62.78 crore in the year ended March 2026 as against Rs 54.82 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales-5.640.58 PL 62.7854.82 15
OPM %158.33-332.76 -83.0278.33 -
PBDT-8.71-1.56 -458 53.9644.45 21
PBT-9.42-2.19 -330 51.1741.89 22
NP-9.10-2.69 -238 37.8230.93 22